Improving medicines value for money in the NHS and the role of biosimilars - assessing progress so far

Godman, Brian (2021) Improving medicines value for money in the NHS and the role of biosimilars - assessing progress so far. In: Westminster Health Forum policy conference, 2021-04-29 - 2021-04-29, Held Online.

Preview

Text. Filename: Godman_WHF_2021_Improving_medicines_value_for_money_in_the_NHS.pdf Accepted Author Manuscript Download (710kB)| Preview

Abstract

Biosimilars are essential to help contain medicine costs and treat patients well with biologicals.

• Share and Export
  

  RDF+XMLBibTeXRIOXX2 XMLRDF+N-TriplesJSONDublin CoreAtomSimple MetadataReferMETSHTML CitationASCII CitationOpenURL ContextObjectEndNoteOpenURL ContextObject in SpanMODSMPEG-21 DIDLEP3 XMLData Cite XMLRIS (EndNote Online, Zotero, Ref manager, etc)RDF+N3Multiline CSV
• Item metadata

  Item type:	Conference or Workshop Item(Poster)
  ID code:	76364
  Dates:	Date Event 29 April 2021 Published
  Subjects:	Medicine > Pharmacy and materia medica
  Department:	Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
  Depositing user:	Pure Administrator
  Date deposited:	06 May 2021 14:33
  Last modified:	11 Nov 2024 17:03
  Related URLs:	Event
  URI:	https://strathprints.strath.ac.uk/id/eprint/76364